| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |